Genomic Biomarkers Global Market Report 2025

Genomic Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for genomic biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Predictive Biomarkers; Prognostic Biomarkers

2) By Disease Indication: Oncology; Cardiovascular Diseases; Neurological Diseases; Renal Disorders; Other Disease Indications

3) By Validation: Analytical Validation; Clinical Validation; Clinical Utility

4) By End-User: Hospitals; Diagnostic Centers; Other End User

Subsegments:

1) By Predictive Biomarkers: Drug Response Biomarkers; Companion Diagnostics Biomarkers; Pharmacodynamic Biomarkers; Predictive Genetic Markers for Disease Susceptibility

2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers; Cardiovascular Disease Prognostic Biomarkers; Neurodegenerative Disease Prognostic Biomarkers; Infectious Disease Prognostic Biomarkers

Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd.; Illumina Inc.; PerkinElmer Inc.; Almac Group

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Genomic Biomarkers Market Characteristics
3. Genomic Biomarkers Market Trends And Strategies
4. Genomic Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Genomic Biomarkers Growth Analysis And Strategic Analysis Framework
5.1. Global Genomic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomic Biomarkers Market Growth Rate Analysis
5.4. Global Genomic Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomic Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomic Biomarkers Total Addressable Market (TAM)
6. Genomic Biomarkers Market Segmentation
6.1. Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Biomarkers
Prognostic Biomarkers
6.2. Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Diseases
Neurological Diseases
Renal Disorders
Other Disease Indications
6.3. Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analytical Validation
Clinical Validation
Clinical Utility
6.4. Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Other End User
6.5. Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Response Biomarkers
Companion Diagnostics Biomarkers
Pharmacodynamic Biomarkers
Predictive Genetic Markers for Disease Susceptibility
6.6. Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Prognostic Biomarkers
Cardiovascular Disease Prognostic Biomarkers
Neurodegenerative Disease Prognostic Biomarkers
Infectious Disease Prognostic Biomarkers
7. Genomic Biomarkers Market Regional And Country Analysis
7.1. Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genomic Biomarkers Market
8.1. Asia-Pacific Genomic Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genomic Biomarkers Market
9.1. China Genomic Biomarkers Market Overview
9.2. China Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genomic Biomarkers Market
10.1. India Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genomic Biomarkers Market
11.1. Japan Genomic Biomarkers Market Overview
11.2. Japan Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genomic Biomarkers Market
12.1. Australia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genomic Biomarkers Market
13.1. Indonesia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genomic Biomarkers Market
14.1. South Korea Genomic Biomarkers Market Overview
14.2. South Korea Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genomic Biomarkers Market
15.1. Western Europe Genomic Biomarkers Market Overview
15.2. Western Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genomic Biomarkers Market
16.1. UK Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genomic Biomarkers Market
17.1. Germany Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genomic Biomarkers Market
18.1. France Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genomic Biomarkers Market
19.1. Italy Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genomic Biomarkers Market
20.1. Spain Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genomic Biomarkers Market
21.1. Eastern Europe Genomic Biomarkers Market Overview
21.2. Eastern Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genomic Biomarkers Market
22.1. Russia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genomic Biomarkers Market
23.1. North America Genomic Biomarkers Market Overview
23.2. North America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genomic Biomarkers Market
24.1. USA Genomic Biomarkers Market Overview
24.2. USA Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genomic Biomarkers Market
25.1. Canada Genomic Biomarkers Market Overview
25.2. Canada Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genomic Biomarkers Market
26.1. South America Genomic Biomarkers Market Overview
26.2. South America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genomic Biomarkers Market
27.1. Brazil Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genomic Biomarkers Market
28.1. Middle East Genomic Biomarkers Market Overview
28.2. Middle East Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genomic Biomarkers Market
29.1. Africa Genomic Biomarkers Market Overview
29.2. Africa Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genomic Biomarkers Market Competitive Landscape And Company Profiles
30.1. Genomic Biomarkers Market Competitive Landscape
30.2. Genomic Biomarkers Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis
31. Genomic Biomarkers Market Other Major And Innovative Companies
31.1. Azenta Inc.
31.2. Novogene Corporation
31.3. Oxford Nanopore Technologies Ltd.
31.4. Celerion
31.5. Quanterix Corporation
31.6. Bio-Rad Laboratories Inc.
31.7. NantHealth Inc.
31.8. Centogene N.V.
31.9. Sophia Genetics SA
31.10. Envisagenics
31.11. Deep Genomics
31.12. Creative Diagnostics
31.13. Macrogen Inc.
31.14. Guardant Health Inc.
31.15. Sema4
32. Global Genomic Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genomic Biomarkers Market
34. Recent Developments In The Genomic Biomarkers Market
35. Genomic Biomarkers Market High Potential Countries, Segments and Strategies
35.1 Genomic Biomarkers Market In 2029 - Countries Offering Most New Opportunities
35.2 Genomic Biomarkers Market In 2029 - Segments Offering Most New Opportunities
35.3 Genomic Biomarkers Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings